Vendor source
Reviewed 11 May 2026
Completeness Comprehensive (81%)
QyScore® is an advanced processing software for automatic labeling and volumetric quantification of segmented central nervous system structures. QyScore® produces a range of automated measures such as whole brain, white matter, grey matter by lobe, cerebellum, white matter abnormalities and brain substructures. Results are available with existing workflows through PACS, AV, AI viewers and in a dedicated 3D UI. QyScore® aims to decrease image reading variability and segmentation errors.
Supported by 3 papers



General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDD
Class:
Class IIa
Verified by Health AI Register
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
A Comparison of fully‐automated segmentation pipelines: QyScore® vs FreeSurfer vs FSL vs ANTs
Alzheimer's & Dementia · Dec 2025
Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects
NeuroImage: Clinical · Jan 2022
Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®
European Radiology · Jan 2022
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Paying clinical customers
Research/test users
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Mar 27, 2022 | Last updated: May 11, 2026